Oftagel (Carbomer 974p)

Carbomer 974P, the active ingredient in Oftagel, is a polymer used as a viscosity‑enhancing agent presented as a gel for ophthalmic use. It helps to retain moisture on the ocular surface and supports healing in dry‑eye and post‑surgical contexts. GNH USA supplies Oftagel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

GNH USA supplies Oftagel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and ophthalmology clinics worldwide.

Oftagel is employed in ophthalmology to manage conditions affecting the ocular surface where a protective, lubricating gel is beneficial.

- Dry eye syndrome: provides long‑lasting lubrication and comfort. - Post‑operative ocular care: supports corneal epithelial healing after surgery. - Contact lens intolerance: reduces friction and improves comfort during lens wear.

Adverse reactions to Oftagel are generally mild and related to the local ocular environment.

Common Side Effects: - Transient blurred vision: temporary reduction in visual clarity after application. - Mild ocular irritation: fleeting stinging or burning sensation. - Redness of the eye: slight conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit or particles. - Swelling of eyelid margins: mild peri‑ocular edema.

Serious or Rare Side Effects: - Allergic contact dermatitis: localized hypersensitivity reaction. - Persistent corneal ulceration: non‑healing epithelial defect. - Severe ocular inflammation: marked uveitis or keratitis. - Vision loss: sudden decrease in visual acuity not related to other causes. - Infection: secondary bacterial or fungal ocular infection. - Anaphylaxis: systemic allergic response, though extremely rare.

When using Oftagel, consider the following safety measures:

- Assess patient history: verify no known hypersensitivity to carbomers or formulation excipients. - Monitor ocular response: watch for signs of irritation or worsening inflammation. - Avoid contamination: use a sterile applicator and discard after single‑use if recommended. - Concomitant therapy: inform healthcare provider of other eye drops or ointments in use. - Pregnancy and lactation: use only if clearly needed and prescribed by a qualified professional. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Oftagel may interact with other ophthalmic products, potentially affecting drug absorption or ocular surface integrity.

Major Interactions (Avoid): - Antimicrobial eye drops containing preservatives: may increase corneal toxicity when used concurrently. - Topical corticosteroids: can alter healing dynamics and increase risk of infection.

Moderate Interactions (Monitor Closely): - Other lubricating gels or artificial tears: may cause excessive tearing or blurred vision. - Mydriatic agents: possible dilution effect reducing pupil‑dilating efficacy. - Contact lens wear: gel residue may affect lens comfort; advise removal before application. - Anti‑glaucoma eye drops: monitor intra‑ocular pressure if used together. - Systemic medications influencing tear production (e.g., antihistamines): assess overall ocular surface health.